LEADER 01852oam  2200553   450 
001 9910711553803321
005 20190325105351.0
035   $a(CKB)5470000002484513
035   $a(OCoLC)1061504188
035   $a(EXLCZ)995470000002484513
100   $a20181107d2018      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aOversight of the Drug Enforcement Administration $ehearing before the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, second session, April 30, 2014
210  1$aWashington :$cU.S. Government Publishing Office,$d2018.
215   $a1 online resource (iii, 63 pages)
225 1 $aS. hrg. ;$v113-886
300   $a"Serial no. J-113-58."
320   $aIncludes bibliographical references.
517   $aOversight of the Drug Enforcement Administration 
606   $aDrug control$zUnited States
606   $aDrug abuse$zUnited States$xPrevention
606   $aOpioid abuse$zUnited States$xPrevention
606   $aDrugs$xPrescribing$zUnited States$xManagement
606   $aDrug abuse$xPrevention$2fast
606   $aDrug control$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2fast
608   $aLegislative hearings.$2lcgft
615  0$aDrug control
615  0$aDrug abuse$xPrevention.
615  0$aOpioid abuse$xPrevention.
615  0$aDrugs$xPrescribing$xManagement.
615  7$aDrug abuse$xPrevention.
615  7$aDrug control.
801  0$bGPO
801  1$bGPO
801  2$bMERUC
801  2$bOCLCF
801  2$bWTU
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910711553803321
996   $aOversight of the Drug Enforcement Administration$93550573
997   $aUNINA